ROBIN LEE: Open Payments
NPI 1174019251 · TAPPAHANNOCK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 17 payments from 11 companies in 2025. Trend: 2023 $825 · 2024 $756 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $209 |
| Medtronic, Inc. | 1 | $131 |
| Vifor Pharma, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $123 |
| ABBVIE INC. | 1 | $123 |
| Novo Nordisk Inc | 1 | $121 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $118 |
| Penumbra, Inc. | 4 | $108 |
| TriSalus Life Sciences, Inc. | 3 | $64 |
| Canon Medical Systems USA, Inc. | 1 | $40 |
Products named: ABRE, Veltassa, BREZTRI, MOUNJARO, QULIPTA, Wegovy, TEZSPIRE, TRINAV INFUSION SYSTEM.
Industry payments across VA — which companies pay providers there.
